ALTEOGEN Inc. 196170.KQ Stock
ALTEOGEN Inc. Price Chart
ALTEOGEN Inc. 196170.KQ Financial and Trading Overview
| ALTEOGEN Inc. stock price | 172000 KRW |
| Previous Close | 43600 KRW |
| Open | 43750 KRW |
| Bid | 43600 KRW x 0 |
| Ask | 43650 KRW x 0 |
| Day's Range | 43550 - 44850 KRW |
| 52 Week Range | 27875 - 65000 KRW |
| Volume | 384.17K KRW |
| Avg. Volume | 819.75K KRW |
| Market Cap | 591.97B KRW |
| Beta (5Y Monthly) | 0.891348 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 65000 KRW |
196170.KQ Valuation Measures
| Enterprise Value | 2.62T KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.384548 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 81.417 |
| Enterprise Value/EBITDA | -86.714 |
Trading Information
ALTEOGEN Inc. Stock Price History
| Beta (5Y Monthly) | 0.891348 |
| 52-Week Change | -7.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 65000 KRW |
| 52 Week Low | 27875 KRW |
| 50-Day Moving Average | 46853 KRW |
| 200-Day Moving Average | 40852.96 KRW |
196170.KQ Share Statistics
| Avg. Volume (3 month) | 819.75K KRW |
| Avg. Daily Volume (10-Days) | 799.13K KRW |
| Shares Outstanding | 13.58M |
| Float | 35.4M |
| Short Ratio | N/A |
| % Held by Insiders | 30.89% |
| % Held by Institutions | 6.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -67.69% |
| Operating Margin (ttm) | -102.85% |
| Gross Margin | 16.57% |
| EBITDA Margin | -93.89% |
Management Effectiveness
| Return on Assets (ttm) | -8.10% |
| Return on Equity (ttm) | -10.43% |
Income Statement
| Revenue (ttm) | 32.2B KRW |
| Revenue Per Share (ttm) | 628.27 KRW |
| Quarterly Revenue Growth (yoy) | 48.89% |
| Gross Profit (ttm) | 4.45B KRW |
| EBITDA | -30232303616 KRW |
| Net Income Avi to Common (ttm) | -21798320128 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 118.74B KRW |
| Total Cash Per Share (mrq) | 2315.96 KRW |
| Total Debt (mrq) | 6.14B KRW |
| Total Debt/Equity (mrq) | 2.8 KRW |
| Current Ratio (mrq) | 5.395 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17103589376 KRW |
| Levered Free Cash Flow (ttm) | -61713510400 KRW |
Profile of ALTEOGEN Inc.
| Country | South Korea |
| State | N/A |
| City | Daejeon |
| Address | 62, Yuseong-daero |
| ZIP | 34054 |
| Phone | 82 4 2384 8780 |
| Website | https://www.alteogen.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; and ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology. The company has a strategic alliance with Kissei Pharmaceutical to develop Aflibercept that has completed pre-clinical trial; and Cristalia for the development of Trastuzumab, which is in the Phase II clinical trial for the treatment of breast cancer. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Q&A For ALTEOGEN Inc. Stock
What is a current 196170.KQ stock price?
ALTEOGEN Inc. 196170.KQ stock price today per share is 172000 KRW.
How to purchase ALTEOGEN Inc. stock?
You can buy 196170.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ALTEOGEN Inc.?
The stock symbol or ticker of ALTEOGEN Inc. is 196170.KQ.
How many shares does ALTEOGEN Inc. have in circulation?
The max supply of ALTEOGEN Inc. shares is 13.58M.
What is ALTEOGEN Inc. Price to Earnings Ratio (PE Ratio)?
ALTEOGEN Inc. PE Ratio is now.
What was ALTEOGEN Inc. earnings per share over the trailing 12 months (TTM)?
ALTEOGEN Inc. EPS is 0 KRW over the trailing 12 months.
ALTEOGEN Inc. 196170.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Composite Index KQ11 | 848.53 KRW 0.64 USD |
-1.39
|
546.42K KRW 412 USD | 842.84 KRW 0.64 USD | 851.22 KRW 0.64 USD | — - | 546.42K KRW 412 USD |
| Kosdaq 100 Index KQ100 | 2012.77 KRW 1.52 USD |
-1.23
|
37.53K KRW 28 USD | 1997.54 KRW 1.51 USD | 2024.99 KRW 1.53 USD | — - | 37.53K KRW 28 USD |
| Kosdaq Other Services Index KQ16 | 3522.26 KRW 2.66 USD |
-2.5
|
15.31K KRW 12 USD | 3508.16 KRW 2.65 USD | 3576.45 KRW 2.7 USD | — - | 15.31K KRW 12 USD |
- {{ link.label }} {{link}}